Priveterra Acquisition Corp. (29)

Browse by Contract Category

Contracts

Form of Letter Agreement (Filed With SEC on January 11, 2023)
Amendment to Settlement and License Agreement dated May 5, 2022, by and between AEON Biopharma, Inc. and Medytox, Inc (Filed With SEC on December 27, 2022)
Amendment to License and Supply Agreement, dated as of July 29, 2022, by and between Daewoong Pharmaceutical Co., Ltd. and AEON Biopharma, Inc (Filed With SEC on December 27, 2022)
Employment Agreement, by and between AEON Biopharma, Inc. and Chris Carr (Filed With SEC on December 27, 2022)
Convertible Promissory Note, dated as of February 15, 2021, issued to Priveterra Sponsor, LLC (Filed With SEC on February 18, 2021)
Settlement and License Agreement dated June 21, 2021, by and between AEON Biopharma, Inc. and Medytox, Inc (Filed With SEC on December 27, 2022)
License and Supply Agreement, dated as of December 20, 2019, by and between Daewoong Pharmaceutical Co., Ltd. and AEON Biopharma, Inc (Filed With SEC on December 27, 2022)
Offer Letter, by and between AEON Biopharma, Inc. and Chad Oh (Filed With SEC on December 27, 2022)
Employment Agreement, by and between AEON Biopharma, Inc. and Marc Forth (Filed With SEC on December 27, 2022)
Letter Agreement, dated February 8, 2021, by and among the Company, its executive officers, its directors and Priveterra Sponsor, LLC (Filed With SEC on February 12, 2021)
Administrative Services Agreement, dated February 8, 2021, by and between the Company and Priveterra Sponsor, LLC (Filed With SEC on February 12, 2021)
Private Placement Warrants Purchase Agreement, dated February 8, 2021, by and among the Company and Priveterra Sponsor, LLC (Filed With SEC on February 12, 2021)
Registration Rights Agreement, dated February 8, 2021, by and among the Company, Priveterra Sponsor, LLC and the other holders party thereto (Filed With SEC on February 12, 2021)
Investment Management Trust Agreement, dated February 8, 2021, by and between the Company and Continental Stock Transfer & Trust Company, as trustee (Filed With SEC on February 12, 2021)
Warrant Agreement, dated February 8, 2021, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent (Filed With SEC on February 12, 2021)
Underwriting Agreement, dated February 8, 2021, by and among the Company and Wells Fargo Securities, LLC and Guggenheim Securities, LLC, as representatives of the several... (Filed With SEC on February 12, 2021)
Form of Registration Rights Agreement between the Registrant and the Holders signatory thereto (Filed With SEC on January 29, 2021)
Form of Administrative Services Agreement between the Registrant and Priveterra Sponsor, LLC (Filed With SEC on January 29, 2021)
Form of Indemnity Agreement (Filed With SEC on January 29, 2021)
Form of Private Placement Warrants Purchase Agreement between the Registrant and Priveterra Sponsor, LLC (Filed With SEC on January 29, 2021)
Form of Investment Management Trust Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on January 29, 2021)
Form of Letter Agreement among the Registrant, Priveterra Sponsor, LLC and each of the executive officers and directors of the Registrant (Filed With SEC on January 29, 2021)
Form of Warrant Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on January 29, 2021)
Specimen Warrant Certificate (Filed With SEC on January 29, 2021)
Specimen Class A Common Stock Certificate (Filed With SEC on January 29, 2021)
Specimen Unit Certificate (Filed With SEC on January 29, 2021)
Form of Underwriting Agreement (Filed With SEC on January 29, 2021)
Securities Subscription Agreement between the Registrant and Priveterra Sponsor, LLC (Filed With SEC on January 21, 2021)
Promissory Note issued to Priveterra Sponsor, LLC (Filed With SEC on January 21, 2021)